📰 Genentech News
Page 240 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
November 9, 2022
Initiated our Phase 2 clinical trial for the potential treatment of familial adenomatous polyposis (FAP)Initiated our Phase 1 clinical trial for t...
November 9, 2022
GuruFocus Article or News written by PRNewswire and the topic is about:
November 9, 2022
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced the appointment of Alan Sandler, M.D., to...
November 8, 2022
Industrialization of biotech vs. the biologization of industry
November 8, 2022
Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Lymphocyte Modulator Global Market Report 2022: By Drug, By Disease" report has been added to ...
November 8, 2022
Jumpstart local businesses to connect and collaborate beyond local reach and expand new market opportunities across regional and national levels for higher ROI
November 8, 2022
/PRNewswire/ -- NeoDynamics AB (Nasdaq First North Growth Market Stockholm: NEOD.ST), a medical device company dedicated to advancing the diagnosis and care of...
November 8, 2022
There are 37 trillion cells that make up the human body. Each of these cells contains the original genetic information from the very first cell. Our DNA is a thousand times smaller than the cell, [...]
November 8, 2022
COVID-19 clinical trial pipeline constitutes 420+ key companies continuously working towards developing 520+ COVID-19 vaccines and drugs, analyzes DelveInsight LAS VEGAS, Nov. 8, 2022 /PRNewswire/
November 8, 2022
– On track to initiate enrollment of two Phase 3 trials with ARV-471 in patients with first- and second-line metastatic breast cancer – – Enrolling...